Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CTKB NASDAQ:LAB NYSE:OWLT NYSE:SENS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTKBCytek Biosciences$3.85-2.3%$3.91$2.37▼$7.63$489.81M1.31877,506 shs916,011 shsLABStandard BioTools$1.28-5.9%$1.30$0.92▼$2.32$488.95M1.311.29 million shs1.60 million shsOWLTOwlet$8.61-4.3%$7.85$2.75▼$10.30$147.54M1.8283,935 shs39,225 shsSENSSenseonics$0.42-6.3%$0.46$0.25▼$1.40$342.17M0.838.18 million shs10.49 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTKBCytek Biosciences-2.28%-3.02%+2.94%+11.59%-23.46%LABStandard BioTools-5.88%-4.48%0.00%-3.03%-27.68%OWLTOwlet-3.96%+1.15%+25.33%-1.32%+85.96%SENSSenseonics-6.25%-9.29%-4.20%-15.48%+23.53%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTKBCytek Biosciences$3.85-2.3%$3.91$2.37▼$7.63$489.81M1.31877,506 shs916,011 shsLABStandard BioTools$1.28-5.9%$1.30$0.92▼$2.32$488.95M1.311.29 million shs1.60 million shsOWLTOwlet$8.61-4.3%$7.85$2.75▼$10.30$147.54M1.8283,935 shs39,225 shsSENSSenseonics$0.42-6.3%$0.46$0.25▼$1.40$342.17M0.838.18 million shs10.49 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTKBCytek Biosciences-2.28%-3.02%+2.94%+11.59%-23.46%LABStandard BioTools-5.88%-4.48%0.00%-3.03%-27.68%OWLTOwlet-3.96%+1.15%+25.33%-1.32%+85.96%SENSSenseonics-6.25%-9.29%-4.20%-15.48%+23.53%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTKBCytek Biosciences 2.29Hold$5.6045.45% UpsideLABStandard BioTools 1.75Reduce$1.5521.09% UpsideOWLTOwlet 2.75Moderate Buy$10.2519.05% UpsideSENSSenseonics 3.40Buy$1.54266.07% UpsideCurrent Analyst Ratings BreakdownLatest OWLT, CTKB, LAB, and SENS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025CTKBCytek BiosciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025LABStandard BioToolsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025OWLTOwletWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/6/2025CTKBCytek BiosciencesZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy9/27/2025CTKBCytek BiosciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025LABStandard BioToolsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025OWLTOwletWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)8/27/2025SENSSenseonicsBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$1.508/27/2025SENSSenseonicsBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$1.508/13/2025LABStandard BioToolsCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold8/13/2025LABStandard BioToolsTD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$1.55(Data available from 10/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTKBCytek Biosciences$196.04M2.50$0.03 per share110.94$3.07 per share1.25LABStandard BioTools$174.43M2.80N/AN/A$1.27 per share1.01OWLTOwlet$78.10M1.88$0.32 per share27.27($1.86) per share-4.63SENSSenseonics$25.47M13.44N/AN/A$0.07 per share6.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTKBCytek Biosciences-$6.02M-$0.05N/A∞N/A-3.27%-1.66%-1.30%11/4/2025 (Estimated)LABStandard BioTools-$138.88M-$0.32N/AN/AN/A-69.08%-20.23%-15.32%10/29/2025 (Estimated)OWLTOwlet-$12.54M-$3.50N/A50.65N/A-54.45%-0.36%-3.26%11/12/2025 (Estimated)SENSSenseonics-$60.39M-$0.10N/AN/AN/A-362.30%-842.25%-67.99%N/ALatest OWLT, CTKB, LAB, and SENS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/4/2025Q3 2025CTKBCytek Biosciences$0.01N/AN/AN/A$51.49 millionN/A10/29/2025Q3 2025LABStandard BioTools-$0.02N/AN/AN/A$18.00 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTKBCytek BiosciencesN/AN/AN/AN/AN/ALABStandard BioToolsN/AN/AN/AN/AN/AOWLTOwletN/AN/AN/AN/AN/ASENSSenseonicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTKBCytek BiosciencesN/A5.224.55LABStandard BioToolsN/A5.164.92OWLTOwletN/A1.150.93SENSSenseonics59.172.472.38Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTKBCytek Biosciences69.46%LABStandard BioTools53.74%OWLTOwlet72.60%SENSSenseonics12.36%Insider OwnershipCompanyInsider OwnershipCTKBCytek Biosciences10.33%LABStandard BioTools23.16%OWLTOwlet52.20%SENSSenseonics3.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTKBCytek Biosciences500127.22 million114.08 millionOptionableLABStandard BioTools620381.99 million293.53 millionOptionableOWLTOwlet10617.08 million8.16 millionNo DataSENSSenseonics90814.68 million573.90 millionN/AOWLT, CTKB, LAB, and SENS HeadlinesRecent News About These CompaniesSenseonics Stock Set to Reverse Split on Monday, October 20th (NYSE:SENS)October 8 at 2:18 AM | marketbeat.comSenseonics announces one-for-twenty reverse stock splitOctober 7, 2025 | msn.comSenseonics reports preliminary Q3 revenue $8.1M, consensus $7.81MOctober 7, 2025 | msn.comSenseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business UpdateOctober 6, 2025 | globenewswire.comSenseonics Holdings, Inc. (NYSE:SENS) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 21, 2025 | marketbeat.comSenseonics reclaims Eversense 365 distribution from AscensiaSeptember 18, 2025 | bioworld.comBSenseonics to retake Eversense CGM commercial control from Ascensia Diabetes CareSeptember 6, 2025 | fiercebiotech.comFSenseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript)September 4, 2025 | seekingalpha.comSenseonics signs MOU with Ascensia Diabetes CareSeptember 3, 2025 | msn.comSenseonics to take over commercial efforts for Eversense 365 from AscensiaSeptember 3, 2025 | drugdeliverybusiness.comDAscensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner SenseonicsSeptember 3, 2025 | businesswire.comSenseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365September 3, 2025 | globenewswire.comHere's Why Senseonics (SENS) Is a Great 'Buy the Bottom' Stock NowAugust 21, 2025 | zacks.comSenseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comSenseonics posts Street-beating Q2 with 37% sales growthAugust 6, 2025 | drugdeliverybusiness.comDSenseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue EstimatesAugust 6, 2025 | zacks.comSenseonics Holdings, Inc. Reports Second Quarter Financial ResultsAugust 6, 2025 | globenewswire.comSenseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call ...July 16, 2025 | gurufocus.comSenseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern TimeJuly 16, 2025 | globenewswire.comSequel Med Tech expects full twiist launch in the fallJuly 15, 2025 | drugdeliverybusiness.comDNew glucose sensors, insulin patch pumps lead ADA’s Scientific SessionsJuly 3, 2025 | medtechdive.comMNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesRocket Lab’s Bullish Case Remains Intact Despite Recent OfferingBy Ryan Hasson | September 24, 2025These 3 Stocks Are Shielded From the AI TakeoverBy Gabriel Osorio-Mazilli | September 15, 2025NuScale, Rocket Lab Face Heavy Insider Selling After SurgesBy Leo Miller | September 26, 2025Rocket Lab's Electron: The Quiet Workhorse Powering MomentumBy Ryan Hasson | October 2, 2025Meta Debuts Next-Gen AI Glasses—A Turning Point for Reality Labs?By Leo Miller | September 28, 2025OWLT, CTKB, LAB, and SENS Company DescriptionsCytek Biosciences NASDAQ:CTKB$3.85 -0.09 (-2.28%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$3.85 0.00 (0.00%) As of 10/10/2025 06:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.Standard BioTools NASDAQ:LAB$1.28 -0.08 (-5.88%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$1.28 0.00 (0.00%) As of 10/10/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Owlet NYSE:OWLT$8.61 -0.39 (-4.33%) Closing price 10/10/2025 03:59 PM EasternExtended Trading$8.04 -0.57 (-6.68%) As of 10/10/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.Senseonics NYSE:SENS$0.42 -0.03 (-6.25%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$0.42 +0.00 (+0.71%) As of 10/10/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Gets Second $420 Target as CPO Win Boosts Outlook AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon Bassett Furniture: Buy Now, Sit Back, and Collect Dividends Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been Constellation Brands: Buffett’s $2.2B Bet May Have Hit Bottom How Gamers Are Powering Microsoft’s Next Wave of Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
